标题
Targeting STAT3 in Cancer Immunotherapy
作者
关键词
-
出版物
Molecular Cancer
Volume 19, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-09-24
DOI
10.1186/s12943-020-01258-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A review of cancer immunotherapy toxicity
- (2020) Lucy Boyce Kennedy et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer
- (2020) Martin Pichler et al. GUT
- Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R-Dependent STING Activation by Tumor-Derived cGAMP
- (2020) Yi Zhou et al. IMMUNITY
- Bifunctional Naphthoquinone Aromatic Amide-Oxime Derivatives Exert Combined Immunotherapeutic and Antitumor Effects through Simultaneous Targeting of Indoleamine-2,3-dioxygenase and Signal Transducer and Activator of Transcription 3
- (2020) Rizhen Huang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges
- (2020) John D. Martin et al. Nature Reviews Clinical Oncology
- LYW-6, a novel cryptotanshinone derived STAT3 targeting inhibitor, suppresses colorectal cancer growth and metastasis
- (2020) Huan Wang et al. PHARMACOLOGICAL RESEARCH
- The biology, function, and biomedical applications of exosomes
- (2020) Raghu Kalluri et al. SCIENCE
- Pancreatic β cell microRNA-26a alleviates type 2 diabetes by improving peripheral insulin sensitivity and preserving β cell function
- (2020) Haixia Xu et al. PLOS BIOLOGY
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transcription activation of circ-STAT3 induced by Gli2 promotes the progression of hepatoblastoma via acting as a sponge for miR-29a/b/c-3p to upregulate STAT3/Gli2
- (2020) Yanfeng Liu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CAR T cells targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
- (2019) Robbie G. Majzner et al. CLINICAL CANCER RESEARCH
- Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy
- (2019) Daniel Shae et al. Nature Nanotechnology
- Development of a Non-Coding-RNA-based EMT/CSC Inhibitory Nanomedicine for In Vivo Treatment and Monitoring of HCC
- (2019) Ruomi Guo et al. Advanced Science
- Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT
- (2019) Xina Zhang et al. Molecular Cancer
- p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma
- (2019) Shufang Jin et al. Molecular Cancer
- The role of regulatory T cells in the response to radiation therapy in head and neck cancer
- (2019) Ayman J Oweida et al. JNCI-Journal of the National Cancer Institute
- STING signaling remodels the tumor microenvironment by antagonizing myeloid-derived suppressor cell expansion
- (2019) Chuan-xia Zhang et al. CELL DEATH AND DIFFERENTIATION
- The transcriptional regulator Sin3A contributes to the oncogenic potential of STAT3
- (2019) Giovanni Gambi et al. CANCER RESEARCH
- Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells
- (2019) Hongwei Du et al. CANCER CELL
- Nanoengineered Immune Niches for Reprogramming the Immunosuppressive Tumor Microenvironment and Enhancing Cancer Immunotherapy
- (2019) Hathaichanok Phuengkham et al. ADVANCED MATERIALS
- STAT3 inhibition enhances CDN-induced STING signaling and antitumor immunity
- (2019) Jianwen Pei et al. CANCER LETTERS
- Targeting Interleukin-6 Signaling in Clinic
- (2019) Sujin Kang et al. IMMUNITY
- Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer
- (2019) In-Hye Ham et al. Molecular Cancer
- Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39
- (2019) Maisa C. Takenaka et al. NATURE NEUROSCIENCE
- Exosomal transfer of p-STAT3 promotes acquired 5-FU resistance in colorectal cancer cells
- (2019) Qian Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- An IL-4/21 Inverted Cytokine Receptor Improving CAR-T Cell Potency in Immunosuppressive Solid-Tumor Microenvironment
- (2019) Yi Wang et al. Frontiers in Immunology
- Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma
- (2019) Eileen M. O’Reilly et al. JAMA Oncology
- LL1, a novel specific STAT3 inhibitor, displays anti‐colorectal cancer activities in vitro and in vivo
- (2019) Zhe Liu et al. BRITISH JOURNAL OF PHARMACOLOGY
- STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade
- (2019) Hannah Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- Placental growth factor regulates the generation of TH17 cells to link angiogenesis with autoimmunity
- (2019) Seung-Ah Yoo et al. NATURE IMMUNOLOGY
- Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer
- (2019) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dendritic Cell Metabolism and Function in Tumors
- (2019) Paolo Giovanelli et al. TRENDS IN IMMUNOLOGY
- The mechanism of the premetastatic niche facilitating colorectal cancer liver metastasis generated from myeloid-derived suppressor cells induced by the S1PR1–STAT3 signaling pathway
- (2019) Qi Lin et al. Cell Death & Disease
- STAT3 Mediates the Differential Effects of Oncostatin M and TNFα on RA Synovial Fibroblast and Endothelial Cell Function
- (2019) Megan M. Hanlon et al. Frontiers in Immunology
- Long noncoding RNA PVT1 promotes hepatoblastoma cell proliferation through activating STAT3
- (2019) Zhenqin Luo et al. Cancer Management and Research
- Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer
- (2019) Fan Luo et al. Journal for ImmunoTherapy of Cancer
- STAT3, a Master Regulator of Anti-Tumor Immune Response
- (2019) Rébé et al. Cancers
- Current Perspectives in Cancer Immunotherapy
- (2019) Theodoulakis Christofi et al. Cancers
- A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo
- (2019) Longchuan Bai et al. CANCER CELL
- STAT3 activation through IL-6/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosis
- (2019) Christina Heichler et al. GUT
- β2 adrenergic receptor–mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells
- (2019) Hemn Mohammadpour et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical investigation of CAR T cells for solid tumors: Lessons learned and future directions
- (2019) Stephen J. Bagley et al. PHARMACOLOGY & THERAPEUTICS
- Myeloid maturation potentiates STAT3-mediated atypical IFN-γ signaling and upregulation of PD-1 ligands in AML and MDS
- (2019) Digdem Yoyen-Ermis et al. Scientific Reports
- Epigenetic initiation of the TH17 differentiation program is promoted by Cxxc finger protein 1
- (2019) Feng Lin et al. Science Advances
- LncRNA-encoded polypeptide ASRPS inhibits triple-negative breast cancer angiogenesis
- (2019) Yirong Wang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296–5p
- (2019) Yu Dong et al. LIFE SCIENCES
- A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity
- (2019) Sajid Khan et al. NATURE MEDICINE
- Long Non-coding RNA ITIH4-AS1 Accelerates the Proliferation and Metastasis of Colorectal Cancer by Activating JAK/STAT3 Signaling
- (2019) Chaojie Liang et al. Molecular Therapy-Nucleic Acids
- Outcomes of switching to dasatinib after imatinib-related low-grade adverse events in patients with chronic myeloid leukemia in chronic phase: the DASPERSE study
- (2018) Dong-Wook Kim et al. ANNALS OF HEMATOLOGY
- ASC-J9 ® suppresses prostate cancer cell invasion via altering the sumoylation-phosphorylation of STAT3
- (2018) WanYing Lin et al. CANCER LETTERS
- Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment
- (2018) Elham Azizi et al. CELL
- JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance
- (2018) Tianyi Wang et al. Cell Metabolism
- Inhibition of SRC family kinases facilitates anti-CTLA4 immunotherapy in head and neck squamous cell carcinoma
- (2018) Guang-Tao Yu et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Signal Transducer and Activator of Transcription Protein 3 (STAT3): an Update on its Direct Inhibitors as Promising Anticancer Agents
- (2018) Arianna Gelain et al. CURRENT MEDICINAL CHEMISTRY
- Structural Biology of STAT3 and Its Implications for Anticancer Therapies Development
- (2018) Jacopo Sgrignani et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phase 2 study of gandotinib (LY2784544) in patients with myeloproliferative neoplasms
- (2018) J. Berdeja et al. LEUKEMIA RESEARCH
- STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy
- (2018) Jin-Fei Chen et al. Molecular Cancer
- STAT3 Cyclic Decoy Demonstrates Robust Antitumor Effects in Non-Small Cell Lung Cancer
- (2018) Christian Njatcha et al. MOLECULAR CANCER THERAPEUTICS
- Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
- (2018) Joseph A. Fraietta et al. NATURE MEDICINE
- A novel chimeric antigen receptor containing a JAK–STAT signaling domain mediates superior antitumor effects
- (2018) Yuki Kagoya et al. NATURE MEDICINE
- STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis
- (2018) Neibla Priego et al. NATURE MEDICINE
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?
- (2018) Jenny D. Beebe et al. PHARMACOLOGY & THERAPEUTICS
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma
- (2018) Carla Lucia Esposito et al. Molecular Therapy-Nucleic Acids
- The CXCR4–STAT3–IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide
- (2018) Hila Shaim et al. Frontiers in Immunology
- Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis
- (2018) John Mascarenhas et al. JAMA Oncology
- Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma
- (2018) Tammy Linlin Song et al. BLOOD
- STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells
- (2018) Prajna Guha et al. ONCOGENE
- PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production
- (2018) Lindsay J. Celada et al. Science Translational Medicine
- STAT3 Cooperates With Phospholipid Scramblase 2 to Suppress Type I Interferon Response
- (2018) Ming-Hsun Tsai et al. Frontiers in Immunology
- Role of the HDAC6/STAT3 pathway in regulating PD-L1 expression in osteosarcoma cell lines
- (2018) Ajimu Keremu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- STAT3 Inhibition Combined with CpG Immunostimulation Activates Antitumor Immunity to Eradicate Genetically Distinct Castration-Resistant Prostate Cancers
- (2018) Dayson Moreira et al. CLINICAL CANCER RESEARCH
- Antisense STAT3 inhibitor decreases viability of myelodysplastic and leukemic stem cells
- (2018) Aditi Shastri et al. JOURNAL OF CLINICAL INVESTIGATION
- ODM-203, a Selective Inhibitor of FGFR and VEGFR, Shows Strong Antitumor Activity, and Induces Antitumor Immunity
- (2018) Tim H. Holmström et al. MOLECULAR CANCER THERAPEUTICS
- Design of amidobenzimidazole STING receptor agonists with systemic activity
- (2018) Joshi M. Ramanjulu et al. NATURE
- Turning foes to friends: targeting cancer-associated fibroblasts
- (2018) Xueman Chen et al. NATURE REVIEWS DRUG DISCOVERY
- Discovery of JND3229 as a New EGFRC797S Mutant Inhibitor with In Vivo Monodrug Efficacy
- (2018) Xiaoyun Lu et al. ACS Medicinal Chemistry Letters
- STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial
- (2018) Matthew J. Reilley et al. Journal for ImmunoTherapy of Cancer
- An RNA Aptamer Targeting the Receptor Tyrosine Kinase PDGFRα Induces Anti-tumor Effects through STAT3 and p53 in Glioblastoma
- (2018) Sorah Yoon et al. Molecular Therapy-Nucleic Acids
- Circular RNA HIPK3 promotes glioma progression by binding to miR-124-3p
- (2018) Daling Hu et al. GENE
- The anti-tumor activity of the STAT3 inhibitor STX-0119 occurs via promotion of tumor-infiltrating lymphocyte accumulation in temozolomide-resistant glioblastoma cell line
- (2017) Yasuto Akiyama et al. IMMUNOLOGY LETTERS
- Cytosolic DNA Promotes Signal Transducer and Activator of Transcription 3 (STAT3) Phosphorylation by TANK-binding Kinase 1 (TBK1) to Restrain STAT3 Activity
- (2017) Hung-Ching Hsia et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease
- (2017) Linda Xiaoyan Li et al. JOURNAL OF CLINICAL INVESTIGATION
- JAK2-binding long noncoding RNA promotes breast cancer brain metastasis
- (2017) Shouyu Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
- (2017) Daniel Öhlund et al. JOURNAL OF EXPERIMENTAL MEDICINE
- PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma
- (2017) V Atsaves et al. LEUKEMIA
- MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis
- (2017) Yan Yang et al. Molecular Cancer
- Lysyl Oxidase 3 Is a Dual-Specificity Enzyme Involved in STAT3 Deacetylation and Deacetylimination Modulation
- (2017) Li Ma et al. MOLECULAR CELL
- The relationship between microRNAs and the STAT3-related signaling pathway in cancer
- (2017) Lin Zhang et al. TUMOR BIOLOGY
- Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human Cancers
- (2017) Oliver M.T. Pearce et al. Cancer Discovery
- Nitidine chloride acts as an apoptosis inducer in human oral cancer cells and a nude mouse xenograft model via inhibition of STAT3
- (2017) Lee-Han Kim et al. Oncotarget
- MMPP Attenuates Non-Small Cell Lung Cancer Growth by Inhibiting the STAT3 DNA-Binding Activity via Direct Binding to the STAT3 DNA-Binding Domain
- (2017) Dong Ju Son et al. Theranostics
- Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
- (2017) Angel Garcia-Diaz et al. Cell Reports
- Micellar nano-carriers for the delivery of STAT3 dimerization inhibitors to melanoma
- (2017) Amir H. Soleimani et al. Drug Delivery and Translational Research
- JAK-STAT-mediated chronic inflammation impairs cytotoxic T lymphocyte activation to decrease anti-PD-1 immunotherapy efficacy in pancreatic cancer
- (2017) Chunwan Lu et al. OncoImmunology
- FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3–CCL2 Signaling
- (2016) Xuguang Yang et al. CANCER RESEARCH
- Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib plus Ipilimumab
- (2016) Sandra P. D'Angelo et al. CLINICAL CANCER RESEARCH
- Inhibition of STAT3 with the Generation 2.5 Antisense Oligonucleotide, AZD9150, Decreases Neuroblastoma Tumorigenicity and Increases Chemosensitivity
- (2016) Seiichi Odate et al. CLINICAL CANCER RESEARCH
- IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer
- (2016) Thomas A Mace et al. GUT
- A phase 1/2, open-label study evaluating twice-daily administration of momelotinib in myelofibrosis
- (2016) Vikas Gupta et al. HAEMATOLOGICA
- The host STING pathway at the interface of cancer and immunity
- (2016) Leticia Corrales et al. JOURNAL OF CLINICAL INVESTIGATION
- Preclinical Characterization of 3β-(N-Acetyl l-cysteine methyl ester)-2aβ,3-dihydrogaliellalactone (GPA512), a Prodrug of a Direct STAT3 Inhibitor for the Treatment of Prostate Cancer
- (2016) Zilma Escobar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Induced protein degradation: an emerging drug discovery paradigm
- (2016) Ashton C. Lai et al. NATURE REVIEWS DRUG DISCOVERY
- Aptamers as targeted therapeutics: current potential and challenges
- (2016) Jiehua Zhou et al. NATURE REVIEWS DRUG DISCOVERY
- SUMOylation and SENP3 regulate STAT3 activation in head and neck cancer
- (2016) Z Zhou et al. ONCOGENE
- A phase 1/2, open-label study evaluating twice-daily administration of momelotinib in myelofibrosis
- (2016) Vikas Gupta et al. HAEMATOLOGICA
- Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation
- (2016) J-t Cheng et al. Oncogenesis
- Role of microRNAs in inflammation-associated liver cancer
- (2016) Huan Lin et al. Cancer Biology & Medicine
- Modular PROTAC Design for the Degradation of Oncogenic BCR-ABL
- (2015) Ashton C. Lai et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer
- (2015) Nagaraj S. Nagathihalli et al. GASTROENTEROLOGY
- IL-10 Potentiates Differentiation of Human Induced Regulatory T Cells via STAT3 and Foxo1
- (2015) Peter Hsu et al. JOURNAL OF IMMUNOLOGY
- Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer
- (2015) Wei Wen et al. Molecular Cancer
- Targeting JAK kinase in solid tumors: emerging opportunities and challenges
- (2015) M Buchert et al. ONCOGENE
- Small-molecule inhibitors targeting the DNA-binding domain of STAT3 suppress tumor growth, metastasis and STAT3 target gene expression in vivo
- (2015) W Huang et al. ONCOGENE
- Phthalimide conjugation as a strategy for in vivo target protein degradation
- (2015) G. E. Winter et al. SCIENCE
- AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer
- (2015) David Hong et al. Science Translational Medicine
- Novel 2-Carbonylbenzo[b]thiophene 1,1-Dioxide Derivatives as Potent Inhibitors of STAT3 Signaling Pathway
- (2015) Peng Ji et al. ACS Medicinal Chemistry Letters
- Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts
- (2015) Jean Albrengues et al. Nature Communications
- LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy
- (2015) Mingxin Zuo et al. Oncotarget
- Loss of STAT3 in murine NK cells enhances NK cell-dependent tumor surveillance
- (2014) D. Gotthardt et al. BLOOD
- A CCL2/ROS autoregulation loop is critical for cancer-associated fibroblasts-enhanced tumor growth of oral squamous cell carcinoma
- (2014) Xia Li et al. CARCINOGENESIS
- Cutting Edge: STING Mediates Protection against Colorectal Tumorigenesis by Governing the Magnitude of Intestinal Inflammation
- (2014) Qifan Zhu et al. JOURNAL OF IMMUNOLOGY
- Tumor-Induced STAT3 Signaling in Myeloid Cells Impairs Dendritic Cell Generation by Decreasing PKC II Abundance
- (2014) M. R. Farren et al. Science Signaling
- Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells
- (2013) Eunhee Kim et al. CANCER CELL
- A phase 2 study of KX2-391, an oral inhibitor of Src kinase and tubulin polymerization, in men with bone-metastatic castration-resistant prostate cancer
- (2013) Emmanuel S. Antonarakis et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- JAK inhibitors suppress t(8;21) fusion protein-induced leukemia
- (2013) M-C Lo et al. LEUKEMIA
- NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer
- (2013) Yihui Fan et al. Protein & Cell
- Dependency of Colorectal Cancer on a TGF-β-Driven Program in Stromal Cells for Metastasis Initiation
- (2012) Alexandre Calon et al. CANCER CELL
- A STAT3-inhibitory hairpin decoy oligodeoxynucleotide discriminates between STAT1 and STAT3 and induces death in a human colon carcinoma cell line
- (2012) Inès Souissi et al. Molecular Cancer
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Spirooxindole Derivative SOID-8 Induces Apoptosis Associated with Inhibition of JAK2/STAT3 Signaling in Melanoma Cells
- (2012) Yan Tian et al. PLoS One
- First-in-Human Trial of a STAT3 Decoy Oligonucleotide in Head and Neck Tumors: Implications for Cancer Therapy
- (2012) Malabika Sen et al. Cancer Discovery
- Alkylation of Cysteine 468 in Stat3 Defines a Novel Site for Therapeutic Development
- (2011) Ralf Buettner et al. ACS Chemical Biology
- ROCK and JAK1 Signaling Cooperate to Control Actomyosin Contractility in Tumor Cells and Stroma
- (2011) Victoria Sanz-Moreno et al. CANCER CELL
- 6-Bromoindirubin-3'-Oxime Inhibits JAK/STAT3 Signaling and Induces Apoptosis of Human Melanoma Cells
- (2011) L. Liu et al. CANCER RESEARCH
- Opposed regulation of type I IFN-induced STAT3 and ISGF3 transcriptional activities by histone deacetylases (HDACS) 1 and 2
- (2011) Laura Icardi et al. FASEB JOURNAL
- A Critical Role for STAT3 Transcription Factor Signaling in the Development and Maintenance of Human T Cell Memory
- (2011) Andrea M. Siegel et al. IMMUNITY
- Enhanced Cancer Immunotherapy Using STAT3-Depleted Dendritic Cells with High Th1-Inducing Ability and Resistance to Cancer Cell-Derived Inhibitory Factors
- (2011) T. Iwata-Kajihara et al. JOURNAL OF IMMUNOLOGY
- Fragment-Based Drug Design and Drug Repositioning Using Multiple Ligand Simultaneous Docking (MLSD): Identifying Celecoxib and Template Compounds as Novel Inhibitors of Signal Transducer and Activator of Transcription 3 (STAT3)
- (2011) Huameng Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosis
- (2010) P. Koppikar et al. BLOOD
- Targeting Stat3 in the Myeloid Compartment Drastically Improves the In vivo Antitumor Functions of Adoptively Transferred T Cells
- (2010) A. Herrmann et al. CANCER RESEARCH
- Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells
- (2010) L. Lin et al. CANCER RESEARCH
- STAT3 Activation of miR-21 and miR-181b-1 via PTEN and CYLD Are Part of the Epigenetic Switch Linking Inflammation to Cancer
- (2010) Dimitrios Iliopoulos et al. MOLECULAR CELL
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes
- (2010) J. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model
- (2009) B Fuh et al. BRITISH JOURNAL OF CANCER
- Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors
- (2009) Heehyoung Lee et al. CANCER CELL
- STAT3 inhibition of gluconeogenesis is downregulated by SirT1
- (2009) Yongzhan Nie et al. NATURE CELL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started